---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-008821"
form_type: "8-K"
ticker: "ODYY"
cik: "0001626644"
company_name: "Odyssey Health, Inc."
filed_at: "2023-12-13T23:59:59+00:00"
generated_at: "2026-06-07T13:30:00.939677+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Odyssey Health shareholders approve asset sale to Oragenics for $1M cash + 8M shares

## Summary
- Stockholders voted 45,032,700 for, 382,191 against the asset sale to Oragenics.
- $1M total cash consideration: $500k paid on signing, second $500k paid after shareholder approval on Dec 11.
- Upon closing, Odyssey will receive 8M shares of Oragenics Convertible Preferred Class F stock (1:1 conversion to common).
- Transaction expected to close before end of 2023.

## SEC filing metadata
- accession: 0001683168-23-008821
- form_type: 8-K
- ticker: ODYY
- cik: 0001626644
- company_name: Odyssey Health, Inc.
- filed_at: 2023-12-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626644/000168316823008821/0001683168-23-008821-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626644/000168316823008821/odyssey_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-008821
- JSON: https://secwatch.observer/filing/0001683168-23-008821.json
- Plain text: https://secwatch.observer/filing/0001683168-23-008821.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.